Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Blood Coagulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05123365
What this trial is testing

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative NeoplasmMPNEssential Thrombocythemia+2 more
University of California, Irvine 27
Not applicableNot Yet RecruitingNCT06619093
What this trial is testing

Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation

Who this might be right for
Sickle Cell Disease (SCD)
Hospices Civils de Lyon 200
Testing effectiveness (Phase 2)Ended earlyNCT01564563
What this trial is testing

Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Acquired Bleeding DisorderBleeding During/Following Surgery
Novo Nordisk A/S 11
Testing effectiveness (Phase 2)Study completedNCT04051307
What this trial is testing

Dual Vaccine Trial in Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Inge Marie Svane 9
Not applicableNot Yet RecruitingNCT07830693
What this trial is testing

Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A

Who this might be right for
Hemophilia A Patient
Nantes University Hospital 553
Not applicableEnded earlyNCT02690428
What this trial is testing

Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers

Who this might be right for
Neoplasms
Clinical Laserthermia Systems AB 3
Not applicableStudy completedNCT04235244
What this trial is testing

The Effect of Three Different Local Cold Applications on Pain and Ecchymosis in Subcutaneous Heparin Injections

Who this might be right for
PainEcchymosis
Istanbul University - Cerrahpasa 54
Post-approval studies (Phase 4)WithdrawnNCT04690322
What this trial is testing

POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies

Who this might be right for
Hemophilia AFactor VIII
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT02391272
What this trial is testing

Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Shandong University 31
Not applicableEnded earlyNCT03603275
What this trial is testing

Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry

Who this might be right for
Hemophilia A
Bayer 3
Not applicableStudy completedNCT04892628
What this trial is testing

Effects of Progressive Resistance Training Compared With Aerobic Training in Patients With Hemophilia

Who this might be right for
Quality of LifeMuscle Weakness
Dow University of Health Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00586651
What this trial is testing

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Who this might be right for
Polycythemia VeraEssential Thrombocytosis
Cephalon 39
Not applicableStudy completedNCT02200419
What this trial is testing

POC - Transfusion Algorithm Cardiac Study

Who this might be right for
Heart Diseases
University Health Network, Toronto 7,402
Testing effectiveness (Phase 2)Study completedNCT06289166
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 25
Not applicableStudy completedNCT05201053
What this trial is testing

Acute Pancreatitis and Coagulation Study

Who this might be right for
Acute Pancreatitis
Region Skane 141
Not applicableLooking for participantsNCT06641375
What this trial is testing

Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)

Who this might be right for
GERD
Asian Institute of Gastroenterology, India 18
Not applicableStudy completedNCT02460445
What this trial is testing

Phlebotomy and Polycystic Ovary Syndrome

Who this might be right for
HyperandrogenismMetabolic Cardiovascular Syndrome
Manuel Luque Ramírez 37
Testing effectiveness (Phase 2)Study completedNCT01336712
What this trial is testing

Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases

Who this might be right for
Chronic LeukemiaAcute LeukemiaHodgkin's Disease+2 more
Northside Hospital, Inc. 30
Large-scale testing (Phase 3)Study completedNCT01731600
What this trial is testing

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 68
Large-scale testing (Phase 3)Study completedNCT00056550
What this trial is testing

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

Who this might be right for
Antithrombin Deficiency, Congenital
rEVO Biologics 14
Next Page